SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC
10-Q/A, 1996-10-16
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: DS BANCOR INC, 8-K, 1996-10-16
Next: GOLDEN BOOKS FAMILY ENTERTAINMENT INC, 8-K/A, 1996-10-16





                            FORM 10-Q/A
                         (Amendment No. 1)
                                
               SECURITIES AND EXCHANGE COMMISSION
                                
                     Washington, D.C.  20549
                     ______________________
                                
      Quarterly Report Pursuant Section 13 or 15(d) of the
                 Securities Exchange Act of 1934
                                
            For Quarterly Period Ended June 30, 1996
                                
                 Commission File Number 0-26694

         SPECIALIZED HEALTH PRODUCTS INTERNATIONAL, INC.
     (Exact name of registrant as specified in its charter)
                                
                                
           Delaware                         93-0945003
(State or other jurisdiction of    (IRS Employer Identification No.)
incorporation or organization)                                            
                                
          655 East Medical Drive, Bountiful, Utah 84010
            (Address of principal executive offices)
                           (Zip Code)
                                
                         (801) 298-3360
      (Registrant's telephone number, including area code)
                                
  Indicate by check mark whether the registrant (1) has filed all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports),  and (2) has been subject  to  such  filing
requirements for the past 90 days.

                        [x]   Yes    [ ] No
                                
   Indicate   the  number of shares outstanding of  each  of  the
issuer's  classes  of common stock, as of the latest  practicable
date.

            Class                 Outstanding as of August 10, 1996
 Common Stock, $.02 par value               8,589,153

<PAGE>

                          PART II - OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K
     
          (a)

                        INDEX TO EXHIBITS
                                

EXHIBIT NO.                  DESCRIPTION OF EXHIBIT

 3(i).1   Restated   Certificate of  Incorporation of the Company. (Incorporated
          by reference  to  Exhibit 3(i).1  of the  Company's current  report on
          Form 8-K, dated July 28, 1995) 

 3(i).2   Articles  of  Incorporation  of   Specialized  Health  Products,  Inc.
          ("SHP")   (Incorporated  by   reference  to  Exhibit  3(i).2  of   the
          Company's Form 10-K, dated December 31, 1995)

 3(i).3   Articles of  Amendment of  SHP (Incorporated by  reference to  Exhibit
          3(i).3 of the Company's Form 10-K, dated December 1995)

 3(i).4   Plan and  Articles of Merger  of  Russco  Resources,  Inc.,  into  SHP
          (Incorporated by reference to Exhibit 3(i).1 to the Company's  current
          report on Form 8-K,  dated July 28, 1995)

3(ii).1   Bylaws of the Company (Incorporated by reference  to  Exhibit  3(ii).1
          of the Company's Form 10-K, dated December 31, 1995) 

3(ii).2   Bylaws of  SHP  (Incorporated by  reference to Exhibit  3(ii).2 of the
          Company's Form 10-K, dated December 31, 1995)         

10.1      Agreement and Plan of Reorganization dated as of June 23, 1995,  among
          the Company,  Russco  Resource, Inc., Scott R.  Jensen and Specialized
          Health Products, Inc. (Incorporated by reference to Exhibit 2.1 of the
          Company's Current Report on Form 8-K, dated July 28, 1995.)

10.2      Placement Agreement between the Company, SHP and U.S. Sachem Financial
          Consultants, L.P.,  dated June 23, 1995  (Incorporated by reference to
          Exhibit 10.2 of the Company's Form 10-K, dated December 31, 1995)

10.3      Form of  Employment Agreement  with  Executive  Officers and Directors
          (Incorporated by reference to Exhibit 10.3 of the Company's Form 10-K,
          dated December 31, 1995)

10.4      Form  of  Indemnity  Agreement  with Executive  Officers and Directors
          (Incorporated by  reference to  Exhibit 4 of the  Company's Form 10-K,
          dated December 31, 1995)

10.5      Form  of  confidentiality  Agreement  (Incorporated  by  reference  to
          Exhibit 10.5 of the Company's Form 10-K, dated December 31, 1995)

10.6      Joint  Venture  Agreement  between  SHP and Zerbec, Inc., dated  as of
          October 30, 1995  (Incorporated  by  reference to  Exhibit 10.6 of the
          Company's Form 10-K, dated December 31, 1995)

27.1      Financial Data Schedule

    (b)  Reports on Form 8-K; 

         None.    


<PAGE>    


                           SIGNATURES
  
     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
  
                                 SPECIALIZED HEALTH PRODUCTS
                                 INTERNATIONAL, INC.:
                                 
                                 
                                 
Date: October 12, 1996           By /s/ David A. Robinson
                                   David A. Robinson
                                   President, Chief Executive
                                   Officer, Director
                                 
                                 
                                 
                                 
Date: October 12, 1996           By /s/ J. Clark Robinson
                                   J. Clark Robinson
                                   Chief Financial Officer,
                                   Director
<PAGE>                           
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FINANCIAL
STATEMENTS  FOR THE PERIOD  ENDED JUNE 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<PERIOD-END>                               JUN-30-1996
<CASH>                                       1,894,275
<SECURITIES>                                         0 
<RECEIVABLES>                                   16,874
<ALLOWANCES>                                         0
<INVENTORY>                                     16,089 
<CURRENT-ASSETS>                             2,274,108
<PP&E>                                       1,371,486
<DEPRECIATION>                                  32,428 
<TOTAL-ASSETS>                               3,945,806
<CURRENT-LIABILITIES>                          133,665   
<BONDS>                                              0  
                                0 
                                          0
<COMMON>                                       170,783
<OTHER-SE>                                   3,640,358
<TOTAL-LIABILITY-AND-EQUITY>                 3,945,806
<SALES>                                         70,367
<TOTAL-REVENUES>                                70,367
<CGS>                                           59,889 
<TOTAL-COSTS>                                1,736,117
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0      
<INTEREST-EXPENSE>                                   0  
<INCOME-PRETAX>                             (1,616,739)
<INCOME-TAX>                                         0   
<INCOME-CONTINUING>                         (1,725,639)
<DISCONTINUED>                                       0  
<EXTRAORDINARY>                                      0
<CHANGES>                                            0  
<NET-INCOME>                                (1,616,739)
<EPS-PRIMARY>                                     (.19)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission